Please use this identifier to cite or link to this item:
|Title:||A THROMBOELASTOGRAPHY STUDY ON THE EVALUATION OF CLOT FORMATION IN PLATELET-DEPLETED WHOLE BLOOD IN THE PRESENCE OF UNFRACTIONATED HEPARIN OR LOW-MOLECULAR WEIGHT HEPARIN|
|Keywords:||Thrombocytopenia, Thromboelastography, Heparin, Platelets|
|Abstract:||The use of an appropriate anticoagulation regiment for the treatment of venous thromboembolism (VTE) in patients with concomitant thrombocytopenia is based on anecdotal evidence and the opinions of managing physicians. The current guidelines suggest that therapeutic levels of anticoagulants may be safely administered to patients who have a minimum platelet count of 50 x 109/L. However, it has recently been suggested that the minimal platelet threshold for safe anticoagulation treatment can be provided at a reduced platelet count of 30 x 109/L. Thus, in order evaluate these platelet threshold we used a thromboelastography (TEG) model to evaluate the clotting parameters of whole blood at predefined platelet counts in the presence of unfractionated heparin (UFH) and low-molecular weight heparin (LMWH). Due to the importance of red blood cells on hemostasis a whole blood TEG model was designed in order to mimic in vivo hemostasis. Clotting was initiated using different concentrations of tissue factor for each anticoagulant at therapeutic and prophylactic levels of UFH and LMWH at predefined platelet counts. In the presence of therapeutic concentrations of either UFH or LMWH, there were no significant differences in TEG parameters of whole blood clots between platelet counts of 30 x 109/L and 50 x 109/L when clotting was driven by the extrinsic pathway. At prophylactic levels of LMWH clot formation was less compromised. Furthermore, no significant difference was noted between platelet-depleted blood (PDB; <10 x 109/L) and 30 x 109/L with respect to r-time. This suggests LMWH at prophylactic levels has no significant bearing on clot formation at a lower platelet threshold versus therapeutic levels of LMWH. Overall, it shows that clot formation is similar for UFH and LMWH when platelet counts are reduced from 50 x 109/L to 30 x 109/L. This work provides insight on the potential for anticoagulation at a reduced platelet threshold in thrombocytopenic conditions.|
|Appears in Collections:||Open Access Dissertations and Theses|
Files in This Item:
|Jason Chung MSc Thesis.docx||MSc Thesis 2015 Medical Science Graduate Program Blood & Vasculature||797.01 kB||Microsoft Word XML||View/Open|
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.